Sebastian Bauer
Overview
Explore the profile of Sebastian Bauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
374
Citations
10453
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larrain C, Pu T, Cox P, Sprott K, Blakely A, Bauer S, et al.
Ann Surg Oncol
. 2025 Feb;
PMID: 39907875
No abstract available.
2.
Keyl J, Keyl P, Montavon G, Hosch R, Brehmer A, Mochmann L, et al.
Nat Cancer
. 2025 Jan;
6(2):307-322.
PMID: 39885364
Despite advances in precision oncology, clinical decision-making still relies on limited variables and expert knowledge. To address this limitation, we combined multimodal real-world data and explainable artificial intelligence (xAI) to...
3.
Schulz T, Gontla R, Teuber A, Beerbaum M, Fletcher B, Muhlenberg T, et al.
J Med Chem
. 2025 Jan;
68(3):3238-3259.
PMID: 39841084
Gastrointestinal stromal tumors (GIST), driven by KIT and PDGFRA mutations, are the most common mesenchymal tumors of the gastrointestinal tract. Although tyrosine kinase inhibitors (TKIs) have advanced treatment, resistance mutations...
4.
Haller V, Reiff C, Hamacher R, Kostbade K, Kaths M, Treckmann J, et al.
J Cancer Res Clin Oncol
. 2025 Jan;
151(1):33.
PMID: 39797929
No abstract available.
5.
Roohani S, Handtke J, Hummedah K, Albertsmeier M, Andreou D, Apostolidis L, et al.
J Cancer Res Clin Oncol
. 2025 Jan;
151(1):30.
PMID: 39755880
Purpose: The management of soft tissue sarcoma (STS) at reference centers with specialized multidisciplinary tumor boards (MTB) improves patient survival. The German Cancer Society (DKG) certifies sarcoma centers in German-speaking...
6.
Slama A, Steinberg H, Collaud S, Okumus O, Hilger R, Bauer S, et al.
Eur Radiol Exp
. 2024 Dec;
8(1):137.
PMID: 39636562
Background: Whole lung transpulmonary chemoembolization using a combination of doxorubicin (DXO) and degradable starch microspheres (DSM-TPCE) might be a promising treatment option in soft tissue sarcoma. To pave the way...
7.
Grothues J, Hardes J, Agaimy A, Collaud S, Podleska L, Farzalyev F, et al.
J Cancer Res Clin Oncol
. 2024 Nov;
150(11):494.
PMID: 39535601
Purpose: Clear cell sarcoma (CCS) of tendons and aponeuroses and CCS-like malignant gastrointestinal neuroectodermal tumor/sarcoma (GINET) are characterized by frequent local and distant relapses, alongside with low efficacy of all...
8.
Haller V, Reiff C, Hamacher R, Kostbade K, Kaths M, Treckmann J, et al.
J Cancer Res Clin Oncol
. 2024 Nov;
150(11):489.
PMID: 39516299
Purpose: The prognosis of patients with metastatic GIST and imatinib-sensitive primary mutations has significantly improved. However, limited data are available to inform patients about outcomes across different lines of treatment....
9.
Cunha I, Latron E, Bauer S, Sage D, Griffie J
J Cell Sci
. 2024 Oct;
137(20).
PMID: 39465533
Machine learning (ML) is transforming the field of image processing and analysis, from automation of laborious tasks to open-ended exploration of visual patterns. This has striking implications for image-driven life...
10.
George S, Blay J, Chi P, Jones R, Serrano C, Somaiah N, et al.
Future Oncol
. 2024 Sep;
20(27):1973-1982.
PMID: 39229786
Somatic activating mutations drive most gastrointestinal stromal tumors (GISTs). Disease progression eventually develops with first-line imatinib, commonly due to secondary mutations, and different kinase inhibitors have various levels of treatment...